Mathilde Nibbio, Claire de Jorna, Marion Lagrée, Diariatou Diallo, Constance Leruste, Melany Liber, François Dubos
{"title":"Verification of tetanus vaccination status of children admitted for animal bites in a pediatric emergency department.","authors":"Mathilde Nibbio, Claire de Jorna, Marion Lagrée, Diariatou Diallo, Constance Leruste, Melany Liber, François Dubos","doi":"10.1080/21645515.2025.2559509","DOIUrl":null,"url":null,"abstract":"<p><p>Animal bites are high-risk wounds for tetanus. Our objective was to verify that children admitted to the pediatric emergency department (PED) for bites had reliable management of the risk of tetanus. This retrospective descriptive study was conducted at Lille University Hospital between 2015 and 2020. Patients under the age of 16 years admitted to the PED for bite wounds were included. The rate of appropriate management was calculated using a strict or pragmatic definition, based on the presentation or not of the health booklet. Among 336 patients included (median age 5 years, 47% boys, 69% wounds on the face; 90% of bites by dogs), 86% had their vaccination status mentioned in the medical observation, more often during daytime hours (<i>p</i> = .02) and by the medical team (as compared to the surgical team; <i>p</i> < 10<sup>-3</sup>). 90% of these were declared up-to-date for their tetanus vaccination. Management was deemed appropriate in 16% according to the strict definition and in 80% using the pragmatic definition. 28 patients were not up to date (10%). Eight of these 28 (29%) had an appropriate management. The management of a bite wound must be systematized with verification of tetanus vaccination status to avoid preventable disasters.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"21 1","pages":"2559509"},"PeriodicalIF":3.5000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12439565/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21645515.2025.2559509","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Animal bites are high-risk wounds for tetanus. Our objective was to verify that children admitted to the pediatric emergency department (PED) for bites had reliable management of the risk of tetanus. This retrospective descriptive study was conducted at Lille University Hospital between 2015 and 2020. Patients under the age of 16 years admitted to the PED for bite wounds were included. The rate of appropriate management was calculated using a strict or pragmatic definition, based on the presentation or not of the health booklet. Among 336 patients included (median age 5 years, 47% boys, 69% wounds on the face; 90% of bites by dogs), 86% had their vaccination status mentioned in the medical observation, more often during daytime hours (p = .02) and by the medical team (as compared to the surgical team; p < 10-3). 90% of these were declared up-to-date for their tetanus vaccination. Management was deemed appropriate in 16% according to the strict definition and in 80% using the pragmatic definition. 28 patients were not up to date (10%). Eight of these 28 (29%) had an appropriate management. The management of a bite wound must be systematized with verification of tetanus vaccination status to avoid preventable disasters.
期刊介绍:
(formerly Human Vaccines; issn 1554-8619)
Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics.
Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.